Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
12.83
-0.35 (-2.66%)
At close: May 15, 2026, 4:00 PM EDT
13.09
+0.26 (2.03%)
After-hours: May 15, 2026, 6:36 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.05 billion as of May 15, 2026. Its market cap has increased by 83.45% in one year.
Market Cap
2.05B
Enterprise Value
2.02B
1-Year Change
83.45%
Ranking
Category
Stock Price
$12.83
Market Cap Chart
Since May 17, 2021, Adaptive Biotechnologies's market cap has decreased from $4.83B to $2.05B, a decrease of -57.49%. That is a compound annual growth rate of -15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.00B | -19.40% |
| Dec 31, 2025 | 2.48B | 176.54% |
| Dec 31, 2024 | 895.17M | 26.08% |
| Dec 29, 2023 | 710.01M | -35.04% |
| Dec 30, 2022 | 1.09B | -72.51% |
| Dec 31, 2021 | 3.98B | -17.68% |
| May 17, 2021 | 4.83B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sotera Health Company | 4.35B |
| RadNet | 4.12B |
| BillionToOne | 3.80B |
| Veracyte | 3.07B |
| Twist Bioscience | 3.06B |
| GRAIL | 2.56B |
| GeneDx Holdings | 1.21B |
| NeoGenomics | 1.08B |